News search

    E.g., 18/07/2024
    E.g., 18/07/2024
    Dr. José María Mendiguren, Director de Servicios Médicos de Banco Santander, Leticia Fernández-Friera, cardióloga del CNIC y del Hospital Universitario HM Montepríncipe, y Dr. Valentín Fuster, Director del CNIC.
    Research
    26 Mar 2019
    JACC: Advanced imaging technology predicts cardiovascular risk from inflammation detected in arteries

    The results, published in JACC, demonstrate the potential of this technology to generate images of the inflammation associated with systemic atherosclerosis; this information will be useful for the study of early stages of this disease and will help to identify individuals who will benefit from early medical intervention
    Pilar Gonzalo, Rosa Nevado, Ricardo Villa-Bellosta, Magda R. Hamczyk, María J. Andrés-Manzano, and Vicente Andrés.
    Research
    12 Mar 2019
    EMBO Molecular Medicine: CNIC scientists discover a new therapeutic target for blocking early atherosclerosis in progeria

    This new results, published in EMBO Molecular Medicine, identify a possible therapeutic target for this genetic disease
    Annalaura Mastrangelo, David Sancho, Salvado Iborra, María Martínez-López y Ruth Conde Garrosa.
    Research
    30 Jan 2019
    Immunity: Scientists identify a new "watchdog" that controls intestinal bacteria

    The study, published in Immunity, shows that some intestinal bacteria, such as Lactobacillus, strengthen the intestinal barrier by interacting with an immune cell receptor called Mincle (Clec4e)
    Research
    16 Jan 2019
    JACC: The duration and quality of sleep is of vital importance in cardiovascular health

    Poor quality sleep increases the risk of atherosclerosis according to the PESA CNIC- Santander Study published in the Journal of the American College of Cardiology (JACC)
    Research
    16 Nov 2018
    Nature Communications: Blocking hypertension with antihypertensive drugs prevents the development of a lethal disease

    The study results, published in the journal Nature Communications, identify several proteins implicated in this disease
    About the CNIC
    1 Oct 2018
    CNIC researcher Guadalupe Sabio receives the IV AstraZeneca Foundation Jóvenes Investigadores prize

    The Fundación AstraZeneca young researcher awards were created to give scientists the opportunities they deserve
    Dr. Andrés Hidalgo
    About the CNIC
    4 Jul 2018
    CNIC coordinates a project from the Leducq Foundation

     ‘Clonal hematopoiesis and atherosclerosis’ will receive a total funding of $6,000,000, of which $712,500 correspond to the CNIC
    De izda. a dcha.: José Antonio Enriquez, María del Mar Muñoz, Fátima Sánchez-Cabo, Luis Jesús Jiménez-Borreguero, Rocío Nieto-Arellano, Andrés González-Guerra, Carlos Torroja, José María Castellanos, y Concepción Jiménez.
    Research
    3 Apr 2018
    Science Translational Medicine: CNIC scientists identify a promising target for the treatment of heart failure

    The study is published in Science Translational Medicine and was conducted by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)
    De izquierda a derecha, Emilio Camafeita, Vanessa Núñez, Cristina Clemente, Alicia G. Arroyo, Laura Alonso-Herranz, Cristina Rius y Vicente Andrés.
    Research
    2 Mar 2018
    Nature Communications: Blocking a protein could improve the effectiveness of intravascular cellular 'policing'

    The study, published in Nature Communications, shows that blockade of the protease MT4-MMP increases the activity of blood-patrolling monocytes in the circulation.
    About the CNIC
    26 Feb 2018
    “The Tribe of the Heart” Campaign

    The Pro CNIC Foundation, presided by Luis de Carlos Beltran, demonstrates in this way once again, the great commitment of the companies that comprise it